Atkinson Edward Morrow III

CIK 00019141642 companiesBOSTON, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001914164

Recent Transactions

43 trades

Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-11$460.43/sh−1,751→ 22,046 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-02-10$468.41/sh−872→ 23,797 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-01-22+3,883→ 24,669 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2026-01-22+3,934→ 20,786 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-11-17$434.58/sh−2,500→ 16,852 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−27,400→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−56,400→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−20,000→ 0 total
Disposition to Issuer
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-10-30−45,150→ 0 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-27$475.34/sh−2,650→ 19,352 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-26$479.61/sh−2,482→ 22,002 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-25$480.95/sh−1,767→ 24,484 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-24$483.28/sh−1,656→ 26,251 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-14$463.46/sh−1,529→ 27,907 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-12+6,211→ 29,436 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-11$459.83/sh−1,747→ 23,225 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-10$467.98/sh−876→ 24,972 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-04+5,132→ 21,104 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2025-02-04+4,744→ 25,848 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2025-02-03+56,400→ 56,400 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-06-12$478.00/sh−7,288→ 15,972 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-06-11$481.96/sh−6,824→ 23,260 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-05-14+14,112→ 30,084 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-26$425.70/sh−883→ 15,972 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-23$431.79/sh−1,654→ 16,855 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-21$421.77/sh−1,201→ 18,509 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-20$420.58/sh−1,125→ 20,511 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-20$420.79/sh−801→ 19,710 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-16$424.01/sh−1,501→ 21,636 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-12$420.24/sh−913→ 23,137 total
Tax Payment
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-09$422.74/sh−832→ 24,050 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-07+4,743→ 24,882 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-06+2,326→ 16,205 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2024-02-06+3,934→ 20,139 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2024-02-01+45,150→ 45,150 total
Exercise/Conversion
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2023-06-01−6,250→ 0 total
Sale
89bio, Inc.$ETNB
Common Stock
2023-06-01$17.91/sh−6,250→ 0 total
Exercise/Conversion
89bio, Inc.$ETNB
Common Stock
2023-06-01$2.61/sh+6,250→ 6,250 total
Exercise/Conversion
89bio, Inc.$ETNB
Common Stock
2023-03-01$4.44/sh+10,000→ 10,000 total
Sale
89bio, Inc.$ETNB
Common Stock
2023-03-01$13.60/sh−10,000→ 0 total
Exercise/Conversion
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2023-03-01−10,000→ 20,000 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2023-02-09+27,400→ 27,400 total
Award
89bio, Inc.$ETNB
Stock Option (Right to Buy)
2022-05-25+6,250→ 6,250 total

Companies

Recent Filings

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210

View on SEC.gov